Sort by
Refine Your Search
-
Country
-
Employer
- UCL;
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- University College London
- National University of Singapore
- Villanova University
- Nanyang Technological University
- University College London (UCL)
- University of Birmingham;
- University of Oslo
- University of Sheffield
- ;
- Center for Drug Evaluation and Research (CDER)
- City of Hope
- Harvard University
- Hong Kong Polytechnic University
- Imperial College London
- NTNU Norwegian University of Science and Technology
- Queen Mary University of London
- Queen's University Belfast
- Technical University of Munich
- The Francis Crick Institute;
- The University of Texas MD Anderson Cancer Center
- UCL
- UCL EE
- UNIVERSITY OF SOUTHAMPTON
- UNIVERSITY OF SURREY
- Universidade do Minho
- University of Birmingham
- University of Sheffield;
- University of Stirling
- University of Surrey
- Western Norway University of Applied Sciences
- 22 more »
- « less
-
Field
-
The UCL Cancer Institute is a £40 million investment in central London based at University College London (UCL), one of the world's top universities and a founding member of the Francis Crick
-
, and neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council, Cancer Research UK, Wellcome, UCL, Imperial College London and King’s College London
-
launched with parallel research undertaken in both 5G+ and 6G for 2030+. About you Strong research expertise in one or more areas directly relevant to ISAC, such as channel modelling, radar/sensing signal
-
launched with parallel research undertaken in both 5G+ and 6G for 2030+. About you Strong research expertise in one or more areas directly relevant to ISAC, such as channel modelling, radar/sensing signal
-
the Intellectual Disabilities Research Institute (IDRIS). The successful applicant will be employed to work on the BEAMS trial which is a multicentre two-arm parallel randomised controlled trial with internal pilot
-
AI research laboratory at the University of Oxford. Oxford is taking a lead role in bringing together more than 80 researchers from Oxford, UCL and Imperial under one unified vision. BOLD Lab will
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 5 hours ago
statistical methods for evaluating parallelism of dose-response curves between test and reference standards through simulation studies. Evaluation of multiple statistical approaches — including logistic
-
is situated in the Intellectual Disabilities Research Institute (IDRIS). The successful applicant will be employed to work on the BEAMS trial which is a multicentre two-arm parallel randomised
-
presence aimed at educating the public and bringing transparency to this emerging science. The Q-BIOMED Hub is led by UCL, supported by £24 million from UKRI and the NIHR, and brings together academic
-
will play a key role in building a parallelized, agent-driven exploration system and integrating a multimodal detection pipeline, ensuring real-time performance, scalability, and deployment readiness in